ScripsAmerica's Managed Specialty Pharmacy on Pace for Record Month
Approved Prescription Orders Total $1.5 Million for the First 15 Days of July
TYSONS CORNER, VA--(Marketwired - Jul 21, 2014) - ScripsAmerica, Inc. (SCRC) today announced that the Company's managed specialty pharmacy reported $1.5 million in approved prescription orders during the first half of July.
"We are pleased to report the continued progress and revenue growth of Scrips' managed specialty pharmacy which is on pace to generate record high sales once again in July," commented ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
